Effect of Melatonin as an Antioxidant Drug to Reverse Hepatic Steatosis: Experimental Model
Introduction. The hepatic steatosis of the nonalcoholic origin or NAFLD is increasing at present, particularly in Western countries, parallel to the increase in obesity, constituting one of the most prevalent hepatic processes in the Western society. Melatonin has been successfully tested in experim...
Saved in:
Main Authors: | Blanca Martínez Soriano, Antonio Güemes, Guillermo Pola, Azucena Gonzalo, Pilar Palacios Gasós, Ana C. Navarro, Roberto Martínez-Beamonte, Jesús Osada, José J. García |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2020-01-01
|
Series: | Canadian Journal of Gastroenterology and Hepatology |
Online Access: | http://dx.doi.org/10.1155/2020/7315253 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Nonlinear relationship between hepatic steatosis index and reversion to normal glucose regulation in Chinese adults with prediabetes
by: Haiyong Zeng, et al.
Published: (2025-02-01) -
A charge reversal nano-assembly prevents hepatic steatosis by resolving inflammation and improving lipid metabolism
by: Haoyu Wang, et al.
Published: (2025-03-01) -
Cerebral Epiphyseal Proteins and Melatonin Modulate the Hepatic and Renal Antioxidant Defense of Rats
by: Vijay K. Bharti, et al.
Published: (2011-01-01) -
Melatonin as a powerful antioxidant
by: Chrustek Agnieszka, et al.
Published: (2021-09-01) -
Hepatic Steatosis, Carbohydrate Intake, and Food Quotient in Patients with NAFLD
by: Concepcion Gonzalez, et al.
Published: (2013-01-01)